A Placebo Controlled,Double-Blind Study of Mecamylamine Treatment for Cocaine Dependence in Patients Enrolled in an Opiate Replacement Program

Abstract

A placebo controlled, double-blind trial of mecamylamine treatment of cocaine dependence was performed in methadone or LAAM maintained subjects who met DSM-IV criteria for cocaine dependence. After an eight-week placebo run-in screening period, 35 subjects were randomly assigned to receive either mecamylamine (6 mg/day) or placebo transdermal patches for a 16-week treatment period. Outcome measures included quantitative urine benzoylecognine (BE) levels, self-report of cocaine use, cocaine craving, global impression scores, mood, retention, and safety. Mecamylamine was well tolerated, and study retention did not differ by treatment group. Evidence for cocaine use, based on urine BE levels and cocaine abstinence rates, did not differ by treatment group. Self reported cocaine use, cocainecraving, and global impression scores showed moderate improvement in both groups, with a significantly greater reduction in cocaine craving (p < 0.05) and self-rated severity of cocaine dependence (p < 0.05) in the placebo group. This pilot study does not support theeffectiveness of mecamylamine for the treatment of cocaine dependence in methadone or LAAM maintained patients.

Keywords

Cocaine dependence treatment mecamylamine nicotine craving

Get full access to this article

View all access options for this article.

References

Magura

, Kang

S Y

, Nwakeze

P C

and Demsky

. 1998. Temporal patterns of heroine and cocaine use among methadone patients. Subst Use Misuse, 33: 2441–2467.

Meandzija

, O'Connor

P G

, Fitzgerald

, Rounsaville

B J

and Kosten

T R

. 1994. HIV infection and cocaine use in methadone maintained and untreated intravenous drug users. Drug Alcohol Depend, 36: 109–113.

Casadonte

, O'Donnell

and Rotrosen

. 1998. LAAM: Four years, four hundred patients later. CPDD Conference. 1998, Scottsdale. pp.19 Abstract Book

Antela

, Casado

J L

, Gonzalez

M J

, Perez

, Perez-Elias

M J

, Montilla

and Bunzon

. 1997. Influence of a methadone maintenance program on the improved outcome of a cohort on injecting drug users with advanced HIV disease. AIDS, 11: 1405–1406.

Rose

J E

, Behm

F M

, Westman

E C

, Levin

E D

, Stein

R M

and Ripka

G V

. 1994. Mecamylamine combined with nicotine skin patches facilitates smoking cessation beyond nicotine patch treatment alone. Clin Pharmaco. Ther, 56: 86–99.

Rose

J E

, Sampson

, Levin

E D

and Henningfield

J E

. 1989. Mecamylamine increases nicotine preference and attenuates nicotine discrimination. Pharmacol Biocem Behav, 32: 933–938.

Reid

M S

, Mickalian

J D

, Delucchi

K L

and Berger

S P

. 1999. A nicotine antagonist, mecamylamine, reduces cue-induced cocaine craving in cocaine-dependent subjects. Neuropsychopharmacology, 20: 297–307.

Chi

and De Wi

. 2003. Mecamylamine attenuates the subjective stimulant-like effects of alcohol in social drinkers. Alcohol Clin Exp Res, 27: 780–786.

Benowitz

N L

, Peyton

, Fong

and Suneel

. 1994. Nicotine metabolic profile in man: comparison of cigarette smoking and transdermal nicotine. J Pharmacol Exp Ther, 268: 296–303.

10.

Rose

J E

, Behm

F M

and Westman

E C

. 1998. Nicotine-mecamylamine treatment for smoking cessation: The role of pre-cessation therapy. Exp Clin Psychopharmacol, 3: 331–343.

11.

Arndt

I O

, Dorozynsky

, Woody

G E

, McLellan

A T

and O'Brien

C P

. 1992. Desipramine treatment of cocaine dependence in methadone-maintained patients. Arch Gen Psychiatry, 49: 888–893.

12.

Kosten

T R

, Morgan

C M

, Falcione

and Schottenfeld

R S

. 1992. Pharmacotherapy for cocaine-abusing methadone-maintained patients using amantadine or desipramine. Arch Gen Psychiatry, 49: 894–898.

13.

Cornish

J W

, Maany

, Fudala

P J

, Neal

, Poole

S A

, Volpicelli

and O'Brien

C P

. 1995. Carbamazepine treatment for cocaine dependence. Drug Alcohol Depend, 38: 221–227.

14.

Montoya

I D

, Levin

F R

, Fudala

P J

and Gorelick

D A

. 1995. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug Alcohol Depend, 38: 213–219.

15.

Ericson

, Blomqvist

, Engel

J A

and Soderpalm

. 1998. Voluntary ethanol intake in the rat and the associated accumbal dopamine overflow are blocked by ventral tegmental mecamylamine. Eur J Pharmacol, 358: 189–196.

16.

Blomqvist

, Hernandez-Avila

C A

, Van Kirk

, Rose

J E

and Kranzler

H R

. 2002. Mecamylamine modifies the pharmacokinetics and reinforcing effects of alcohol. Alcohol Clin Exp Res, 26: 326–331.

17.

Levin

E D

, Mead

, Rezvani

A H

, Rose

J E

, Gallivan

and Gross

. 2000. The nicotinic antagonist mecamylamine preferentially inhibits cocaine vs. food self-administration in rats. Physiol Behav, 71: 565–570.

18.

Glick

S D

, Maisonneuve

I M

, Kitchen

B A

and Fleck

M W

. 2002. Antagonism of alpha 3 beta 4 nicotinic receptors as a strategy to reduce opioid and stimulant self-administration. Eur J Pharmacol, 438: 99–105.